Brief: RXO Q3 Adjusted EPS USD 0.05 Vs. IBES Estimate USD 0.04
Nov 07 (Reuters) - RXO Q3 EPS USD -1.81. * Q3 adjusted net income USD 7 million vs. IBES estimate USD 5.36 million * Q3 adjusted EBITDA USD 33 million vs. IBES estimate USD 30.6 million * Q3 adjusted EBITDA margin 3.2% * Q3 revenue USD 1,040 million vs. IBES estimate USD 975.6 million